Abstract
The invention relates to oral medicine for treating lung cancer, in particular to a traditional Chinese medicine oral decoction for treating lung cancer. The traditional Chinese medicine oral decoction is prepared from Chinese herbal medicines. The traditional Chinese medicine oral decoction is characterized by comprising, by weight, 20-90g of radix astragali, 10-30g of herba solani lyrati, 10-40g of bulbus fritillariae cirrhosae, 10-50g of herba scutellariae barbatae, 10-80g of poria, 5-20g of bulbus lilii, 5-20g of radix platycodi, 10-45g of herba houttuyniae, 10-20g of radix stemonae, 5-15g of radix adenophorae, 20-80g of folium ilicis cornutae, 30-60g of radix ophiopogonis, 10-30g of rhizoma atractylodis macrocephalae, 5-20g of semen armeniacae amarae, 9-14g of centipede, 5-12g of herba rabdosiae, 3-9g of radix ginseng, 11-15g of agkistrodon, 10-15g of water caltrop shells, 2-12g of herba hedyotidis diffusae, 10-18g of rhizoma curcumae, 10-25g of radix peucedani, 7-11g of pericarpium citri reticulatae viride, 8-12g of semen alpiniae katsumadai, 5-15g of lucid ganoderma and 5-11g of mylabris fried with vinegar. The components of the traditional Chinese medicine oral decoction provided by the present invention are used in combination, and the traditional Chinese medicine oral decoction has the effects of clearing away heat and toxic materials, resisting viruses, resisting cancers and the like. The traditional Chinese medicine oral decoction can be organically combined with Western medicine methods, such as operations, radiotherapy and chemotherapy, for comprehensive treatment, and has the effects of decreasing toxicity and increasing efficacy, thereby prolonging the life time of patients.
Description
technical field
[0001] The invention relates to an oral drug for treating lung cancer, in particular to a traditional Chinese medicine oral decoction for treating lung cancer made from plant Chinese herbal medicine. Background technique
[0002] Lung cancer refers to malignant tumors from bronchi or bronchioles, epidermal cells, accounting for 90-95% of lung parenchymal malignant tumors. At present, the early treatment of lung cancer is surgery-based, combined with radiation therapy and chemotherapy. Although surgery can remove the cancer, there is still residual cancer, or regional lymph node metastasis, or tumor thrombi in blood vessels, etc., and the probability of recurrence and metastasis is very high. Chemoradiation has many complications and even causes loss of many functions. For patients with advanced tumors, the effect of radiotherapy is not complete. At the same time, for patients with poor physique and older age, continuing radiotherapy can only lead to weaker...
